Поиск | Pikumil

Stephen Grey добавлена новая статья Health
2026-05-11 14:58:42 -

Key Drivers Accelerating Growth in the Adalimumab Market
The global Adalimumab Market is witnessing significant growth due to the increasing prevalence of autoimmune disorders such as rheumatoid arthritis, Crohn’s disease, ulcerative colitis, psoriasis, and psoriatic arthritis. Adalimumab is a widely used biologic therapy that targets tumor necrosis factor-alpha (TNF-α), helping reduce inflammation and improve patient outcomes in chronic...

0 Комментарии 0 Поделились 246 Просмотры 0 предпросмотр

Войдите, чтобы отмечать, делиться и комментировать!
Prasad Shinde добавлена новая статья Другое
2025-12-10 19:49:38 -

The Adalimumab Biosimilar Market: A Deep Dive into Growth Trends, Competitive Dynamics, and Forecast to 2030
The Adalimumab Biosimilar Market size was valued at an estimated USD 772.1 million in 2023 and is projected to skyrocket to approximately USD 3.87 billion by 2030, representing an impressive Compound Annual Growth Rate (CAGR) of 25.9% over the forecast period. Data Bridge Market Research analyses that the adalimumab biosimilar market which is USD 598.30...

0 Комментарии 0 Поделились 1Кб Просмотры 0 предпросмотр

Войдите, чтобы отмечать, делиться и комментировать!
Rohit Katkam добавлена новая статья Health
2026-03-12 05:11:13 -

Global Adalimumab Market to Reach USD 195 Million by 2034, Growing at a CAGR of 4.9% During 2025–2034
According to a new report from Intel Market Research, the global Adalimumab Market was valued at USD 141 million in 2024 and is projected to reach USD 195 million by 2034, growing at a CAGR of 4.9% during the forecast period (2025–2034). This growth is primarily driven by the increasing prevalence of autoimmune diseases and expanding treatment indications for adalimumab. What is...

0 Комментарии 0 Поделились 510 Просмотры 0 предпросмотр

Войдите, чтобы отмечать, делиться и комментировать!